Assessing the economics of biologic and small molecule therapies for the treatment of moderate to severe ulcerative colitis in Japan: a cost per responder analysis of upadacitinib
Article in Journal of Medical Economics (April 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Editorial: If STRIDE‐II is the hammer, then Crohn's disease and ulcerative colitis are not the same nails
Article in Alimentary Pharmacology & Therapeutics (August 2023)
Lack of Benefit for Early Escalation to Advanced Therapies in Ulcerative Colitis: Critical Appraisal of Current Evidence
Article in Journal of Crohn's and Colitis (June 2023)